Expiring UK Public Contracts: Retender Radar

Explore UK public contracts by expiry date, with buyers, incumbent suppliers and extension options. Estimated end dates are labelled; expiry does not guarantee a new tender.

in Retenders

Syntax:"exact phrase"cleaning OR cateringsoftware -consultancy(cleaning OR catering) AND hospitalgovern*admin+defence

Contracts ending in the all future end dates

Showing 1,081–1,095

  1. Ends · in 610 days

    Proprietary Drugs

    eTenderwales · Nationwide (UK), Wales (Cymru)

    Incumbent: Amicus Therapeutics UK Operations Ltd · Last contest: 75 bids

    Proprietary Drugs

    • Pharmaceutical products
    Published value
    £29m
    Annual run-rate
    —start date not published
    Term
    Ends 30 Jun 2028 · start not published
    Reference
    ocds-h6vhtk-04ac47
  2. Ends · in 610 days

    Proprietary Drugs

    eTenderwales · Nationwide (UK), Wales (Cymru)

    Incumbent: Astellas Pharma Ltd · Last contest: 75 bids

    Proprietary Drugs

    • Pharmaceutical products
    Published value
    £28m
    Annual run-rate
    —start date not published
    Term
    Ends 30 Jun 2028 · start not published
    Reference
    ocds-h6vhtk-04ac47
  3. Ends · in 610 days

    Proprietary Drugs

    eTenderwales · Nationwide (UK), Wales (Cymru)

    Incumbent: Sanofi · Last contest: 75 bids

    Proprietary Drugs

    • Pharmaceutical products
    Published value
    £28m
    Annual run-rate
    —start date not published
    Term
    Ends 30 Jun 2028 · start not published
    Reference
    ocds-h6vhtk-04ac47
  4. Ends · in 610 days

    Biologic and Biosimilar Medicines

    eTenderwales · Nationwide (UK), Wales (Cymru)

    Incumbent: Biogen Idec Ltd · Last contest: 19 bids

    Biologic and Biosimilar Medicines

    • Pharmaceutical products
    Published value
    £23m
    Annual run-rate
    —start date not published
    Term
    Ends 30 Jun 2028 · start not published
    Reference
    ocds-h6vhtk-049b93
  5. Ends · in 610 days

    Aseptics Medicines (Including Cytotoxics)

    Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts) · NHS & health · Nationwide (UK), Wales (Cymru)

    Incumbent: Janssen · Last contest: 49 bids

    Aseptics Medicines (Including Cytotoxics)

    • Pharmaceutical products
    Published value
    £22m
    Annual run-rate
    —start date not published
    Term
    Ends 30 Jun 2028 · start not published
    Reference
    ocds-h6vhtk-0496e2
  6. Ends · in 610 days

    Proprietary Drugs

    eTenderwales · Nationwide (UK), Wales (Cymru)

    Incumbent: Eli Lilly & Company Ltd · Last contest: 75 bids

    Proprietary Drugs

    • Pharmaceutical products
    Published value
    £22m
    Annual run-rate
    —start date not published
    Term
    Ends 30 Jun 2028 · start not published
    Reference
    ocds-h6vhtk-04ac47
  7. Ends · in 610 days

    Antiretroviral Drugs

    Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts) · NHS & health · Wales (Cymru)

    Incumbent: Gilead Sciences Ltd · Last contest: 14 bids

    Antiretroviral Drugs

    • Pharmaceutical products
    Published value
    £20m
    Annual run-rate
    —start date not published
    Term
    Ends 30 Jun 2028 · start not published
    Reference
    ocds-h6vhtk-04ac3a
  8. Ends · in 610 daysExtension option · up to 30 Jun 2030Panel · 10 suppliers

    Transitional Drugs 7

    NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · Central government · Wales (Cymru)

    Panel: Amgen Ltd, Celix Pharma Ltd., Celltrion Healthcare Uk Ltd +7 more

    The provision of Drugs that have recently lost exclusivity

    Published value
    £17m
    Annual run-rate
    —panel, not one supplier
    Term
    1 Jul 2026 → 30 Jun 2028 · 2 yrs · up to 30 Jun 2030 with extensions
    Reference
    ocds-h6vhtk-067da4
  9. Ends · in 610 days

    Proprietary Drugs

    eTenderwales · Nationwide (UK), Wales (Cymru)

    Incumbent: UCB Pharma · Last contest: 75 bids

    Proprietary Drugs

    • Pharmaceutical products
    Published value
    £16m
    Annual run-rate
    —start date not published
    Term
    Ends 30 Jun 2028 · start not published
    Reference
    ocds-h6vhtk-04ac47
  10. Ends · in 610 days

    Proprietary Drugs

    eTenderwales · Nationwide (UK), Wales (Cymru)

    Incumbent: Pfizer Ltd · Last contest: 75 bids

    Proprietary Drugs

    • Pharmaceutical products
    Published value
    £13m
    Annual run-rate
    —start date not published
    Term
    Ends 30 Jun 2028 · start not published
    Reference
    ocds-h6vhtk-04ac47
  11. Ends · in 610 days

    Proprietary Drugs

    eTenderwales · Nationwide (UK), Wales (Cymru)

    Incumbent: Astra Zenica · Last contest: 75 bids

    Proprietary Drugs

    • Pharmaceutical products
    Published value
    £12m
    Annual run-rate
    —start date not published
    Term
    Ends 30 Jun 2028 · start not published
    Reference
    ocds-h6vhtk-04ac47
  12. Ends · in 610 days

    Antiretroviral Drugs

    Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts) · NHS & health · Wales (Cymru)

    Incumbent: ViiV Healthcare · Last contest: 14 bids

    Antiretroviral Drugs

    • Pharmaceutical products
    Published value
    £12m
    Annual run-rate
    —start date not published
    Term
    Ends 30 Jun 2028 · start not published
    Reference
    ocds-h6vhtk-04ac3a
  13. Ends · in 610 days

    Proprietary Drugs

    eTenderwales · Nationwide (UK), Wales (Cymru)

    Incumbent: Camurus AB · Last contest: 75 bids

    Proprietary Drugs

    • Pharmaceutical products
    Published value
    £11m
    Annual run-rate
    —start date not published
    Term
    Ends 30 Jun 2028 · start not published
    Reference
    ocds-h6vhtk-04ac47
  14. Ends · in 610 days

    Biologic and Biosimilar Medicines

    eTenderwales · Nationwide (UK), Wales (Cymru)

    Incumbent: Amgen Ltd · Last contest: 19 bids

    Biologic and Biosimilar Medicines

    • Pharmaceutical products
    Published value
    £8.8m
    Annual run-rate
    —start date not published
    Term
    Ends 30 Jun 2028 · start not published
    Reference
    ocds-h6vhtk-049b93
  15. Ends · in 610 days

    Proprietary Drugs

    eTenderwales · Nationwide (UK), Wales (Cymru)

    Incumbent: NOVARTIS PHARMACEUTICALS UK LIMITED · Last contest: 75 bids

    Proprietary Drugs

    • Pharmaceutical products
    Published value
    £8.7m
    Annual run-rate
    —start date not published
    Term
    Ends 30 Jun 2028 · start not published
    Reference
    ocds-h6vhtk-04ac47

When contracts end · Medical equipments, pharmaceuticals
i

When contracts here run out.

Published contracts by their end date. No end date, not counted.

An end date does not confirm a new procurement.

1,340 contracts and agreements end within 24 months, 2,052 in total · £2.7bn published GBP values end in the all future end dates, exc. VAT; framework and DPS values, concession values and other ceiling-like amounts are excluded, so this is not a spend forecast.

  1. Next 3 months190
  2. 3–6 months226
  3. 6–12 months361
  4. 12–24 months563

Top sectors, all future end dates
i

When contracts here run out.

Published contracts by their end date. No end date, not counted.

An end date does not confirm a new procurement.

Contracts ending in the chosen window, by category.

CPV division of the procedure; a contract with several divisions counts in each. Top 8 of 45 divisions shown.

How to read the radar
  • End date is the contract period end the buyer published on the notice (or on the lot). Where the notice gives only a duration, the end is estimated as the signature date (or, without one, the publication date) plus that duration, and the row says so. Contracts with neither are not on the radar; neither are contracts the buyer cancelled or terminated early.
  • List or panel totals. When one total is repeated on every provider of an approved list or panel, it is shown on the row but never added to the GBP totals or used for a run-rate.
  • Extension option means the notice publishes a renewal or option clause; the buyer may extend. Hiding these rows shows contracts without a published option, but does not establish that the buyer will procure them again.
  • Incumbent is the supplier named on the award behind the contract. A panel (several suppliers on one award) is shown as a panel; no single incumbent is invented.
  • Annual run-rate = published GBP value ÷ published term for a single supplier and a term of six months or more. Values linked to a framework or DPS have no run-rate until we can tell whether they are a ceiling or a contract. The annual sort ranks comparable values excluding VAT first; gross-only values remain visible on their rows. This is not actual annual spend.
  • Counts are exact for the time-horizon and sector filters. A parent framework or DPS counts once; call-offs published by other buyers count separately. Where the parent cannot be identified, agreements stay separate and are marked as linked to a framework or DPS; check the source notice before treating their date or value as a single contract fact. With other filters, a result above 1,000 rows shows as “1,000+”.
  • Source. Official UK procurement notices, reused under the Open Government Licence v3.0; the radar is rebuilt nightly. How we count: methodology.